Zekun Li Zhenping Chen Xiaoling Cheng Xinyi Wu Gang Li Yingzi Zhen Man-Chiu Poon Runhui Wu
10.1177/2058738420934618
Int J Immunopathol Pharmacol
2020 Jan-Dec;34:2058738420934618.
fviii immunogenicity inhibitor previously treated patient severe haemophilia a vaccination
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32627611/
Antibodies, Neutralizing / blood Chickenpox Vaccine / administration & dosage Coagulants / immunology Diphtheria-Tetanus-Pertussis Vaccine / administration & dosage Factor VIII / immunology Hemophilia A / drug therapy Hemorrhage / etiology Hepatitis A Vaccines / administration & dosage
Antibodies, Neutralizing / blood Chickenpox Vaccine / administration & dosage Coagulants / immunology Diphtheria-Tetanus-Pertussis Vaccine / administration & dosage Factor VIII / immunology Hemophilia A / drug therapy Hemorrhage / etiology Hepatitis A Vaccines / administration & dosage Case Reports Coagulants / administration & dosage Drug Administration Schedule Factor VIII / administration & dosage Hemophilia A / complications Hemophilia A / diagnosis Humans Infant Male Severity of Illness Index Treatment Outcome Vaccination Antibodies, Neutralizing Chickenpox Vaccine Coagulants Diphtheria-Tetanus-Pertussis Vaccine Hepatitis A Vaccines F8 protein, human Factor VIII
PMC7338642
32627611
A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations
2020